| Literature DB >> 28159845 |
Linda Lang1,2, Angela Clifford1, Li Wei3, Dongmei Zhang4, Daryl Leung5, Glenda Augustine6, Isaac M Danat1, Weiju Zhou1, John R Copeland7, Kaarin J Anstey8, Ruoling Chen1,2.
Abstract
OBJECTIVES: Detection of dementia is essential for improving the lives of patients but the extent of underdetection worldwide and its causes are not known. This study aimed to quantify the prevalence of undetected dementia and to examine its correlates. METHODS/SETTING/PARTICIPANTS: A systematic search was conducted until October 2016 for studies reporting the proportion of undetected dementia and/or its determinants in either the community or in residential care settings worldwide. Random-effects models calculated the pooled rate of undetected dementia and subgroup analyses were conducted to identify determinants of the variation. PRIMARY AND SECONDARY OUTCOME MEASURES: The outcome measures of interest were the prevalence and determinants of undetected dementia.Entities:
Keywords: GERIATRIC MEDICINE
Mesh:
Year: 2017 PMID: 28159845 PMCID: PMC5293981 DOI: 10.1136/bmjopen-2016-011146
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Forest plot for these 23 studies.
Meta-rate of undetected dementia by location of study
| Location of study | Number of studies | Number of patients | Number of cases | Meta-prevalence (% (95% CI)) |
|---|---|---|---|---|
| Country* | ||||
| UK | 3 | 664 | 271 | 43.1 (34.6 to 52.0) |
| Those in Europe except UK | 8 | 1057 | 661 | 58.2 (48.3 to 67.5) |
| USA | 8 | 1613 | 934 | 60.7 (51.7 to 69.0) |
| Canada | 2 | 39 712 | 28 093 | 70.7 (70.3 to 71.2) |
| Those in Asia | 2 | 400 | 373 | 93.2 (90.3 to 95.3) |
| Setting | ||||
| Community-based only | 15 | 2816 | 1776 | 63.7 (54.8 to 71.8) |
| Residential or nursing care only | 5 | 40 249 | 28 313 | 50.9 (29.5 to 71.9) |
| Population study (community and/or residential) | 3 | 381 | 243 | 65.8 (49.7 to 79.0) |
*The meta-rate from the 11 studies from Europe is 53.7% (44.0% to 63.1%) and from North America is 62.9% (54.4% to 70.6%).
Undetected dementia in relation to other factors
| Variable | Number of studies | Number of patients | Number of cases | Meta-prevalence (% (95% CI)) |
|---|---|---|---|---|
| Minimum age of studied patients in the study | ||||
| <70 | 8 | 1333 | 966 | 74.6 (60.4 to 85.0) |
| 70–79 | 7 | 1237 | 738 | 61.9 (51.0 to 71.7) |
| ≥80 | 2 | 118 | 60 | 45.8 (26.3 to 66.7) |
| Unknown | 6 | 40 758 | 28 568 | 49.8 (34.4 to 65.3) |
| Per cent of females in the study | ||||
| ≥65 | 9 | 41 544 | 29 196 | 62.1 (54.3 to 69.3) |
| <65 | 5 | 810 | 643 | 78.4 (58.7 to 90.2) |
| Unknown | 9 | 1092 | 493 | 49.4 (40.0 to 58.8) |
| Methods of dementia diagnosis | ||||
| GP | 4 | 899 | 627 | 68.4 (40.8 to 87.2) |
| Medical record | 16 | 23 71 | 1415 | 60.6 (53.2 to 67.4) |
| Facility record | 2 | 39 825 | 28 162 | 68.1 (60.7 to 74.7) |
| Care plan | 1 | 351 | 128 | 36.5 (31.4 to 41.7) |
| Identification of dementia | ||||
| MMSE | 6 | 1270 | 719 | 54.3 (40.7 to 67.3) |
| DSM-III/IV | 5 | 326 | 209 | 67.0 (54.6 to 77.5) |
| ICD-10 | 2 | 180 | 110 | 58.6 (13.5 to 92.8) |
| CASI | 2 | 186 | 82 | 51.4 (28.3 to 73.9) |
| CERAD | 2 | 632 | 335 | 51.8 (42.2 to 61.3) |
| Others* | 6 | 40 852 | 28 877 | 71.2 (58.2 to 81.4) |
| Year of study publication | ||||
| <2005 | 11 | 1070 | 592 | 57.2 (47.1 to 66.8) |
| ≥2005 | 12 | 42 358 | 29 740 | 65.3 (56.5 to 73.2) |
*Others including CAMDEX, CMSQ, SPMSQ, neuropsychological battery, 10/66 and CPS.
CAMDEX, Cambridge Mental Disorders of the Elderly Examination; CASI, Cognitive Abilities Screening Instrument; CERAD, Consortium to Establish a Registry for Alzheimer's Disease; CMSQ, Canadian Mental Status Questionnaire; CPS, Cognitive Performance Scale; DSM-III/IV, Diagnostic and Statistical Manual of Mental Disorders Third/Fourth Edition; GP, general practitioner; ICD-10, International Classification of Diseases 10th Edition; MMSE, Mini-Mental State Examination; SPMSQ, Short Portable Mental Status Questionnaire.